Interview: Annie Hubert – Senior Director, EU Section and Public Policy, Alliance for Regenerative Medicine (ARM)
“ "Market access is a big priority for the organization as a whole and this is also true in Europe." ”
“ "Market access is a big priority for the organization as a whole and this is also true in Europe." ”
“ "The openness of some public health institutions such as the Bulgarian Drug Agency (BDA) and the Ministry of Health towards helping the industry to comply with… ”
“ "The idea is not to cut out or remove the dermatologist from the equation because they should be part of the concept." ”
“ "As long as you have a good quality, experience in the field of formulation and excellent reputation there will be sufficient business." ”
“ "All over Europe the population age is increasing and therefore the number of citizens living under social security is also increasing." ”
“ "Any patient in Bulgaria can easily reach the highest level of experts within a very short period of time" ”
“ "Looking to the BDA’s next steps, we are aiming to further expand our capabilities in conducting GMP inspections in Asia by 2017/2018." ”
“ "This national health strategy is very significant for pharmacists and pharmacies because in addition to the introduction of e-health and e-prescription the whole pharmacy health service… ”
“ "Personalised medicine is one of the key drivers in the pharma industry, but I must admit that I am concerned about the sustainability of the current… ”
“ "There are around 30 companies doing genetic testing in Europe and thankfully we supply 75 percent of the market. In fact, Novogenia is one of the… ”
“ "Bulgarian patients’ access to innovative medicines has drastically improved over the last decade" ”
“ "We believe having an approach based around long-term stability allows our customers to trust and rely on Théa, and this will continue well into the future." ”
See our Cookie Privacy Policy Here